We further analyzed the OS and PFS of IDH WT GBM patients using Cox proportional-hazard models adjusted for factors known to influence the patients’ outcome, such as age [25], Karnofsky Performance Scale (KPS) [26], extent of surgical resection [27], therapy [28] and MGMT methylation status [29]. The gene discussed is MGMT; the disease is glioblastoma.